Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.
Join Dr. Nicola Hanania, Dr. Stephanie Christenson, and Dr. Mario Castro as they explore the shared and unique pathophysiological features of type 2 inflammation-driven asthma and COPD and the real-world impact on patients.